| |
| Aredia® (pamidronate) and
Zometa® (zolendronate) |
| |
- Novartis
|
| Maxamine® (histamine dihydrochloride) |
| |
- Maxim Pharmaceuticals
|
| Panorex (Colon Cancer / Dukes
C) |
| |
|
| 776C85 (refractory solid tumours) |
| |
|
| 506U78 (purine analogue for
CLL, NHL & ALL) |
| |
- GlaxoWellcome (1998)
|
| CP-358,774 (EGFr/TKI) |
| |
- Pfizer Inc. (1999)
|
| Lasofoxifene (SERM) |
| |
- Pfizer Inc. (2000)
|
| NSCLC (radiosensitizing therapy) |
| |
Serono S.A. (2000)
|
| Colorectal Cancer |
| |
- Ethicon EndoSurgery (2000)
|
| Xinlay / atrasentan |
| |
- Abbott
|
| Taxotere®/docetaxel |
| |
- Sanofi-avents |
